top of page

Ourobionics is proud to officially announce its participation in NXTGEN HIGHTECH, a National Growth Fund program which will invest as much as € 1 billion until 2030 in over 60 projects led by partners




In the coming years, along with several partners within the "biomedical production technologies" domain, we will be working towards establishing the first ever one-stop-shop: a facility designed to manufacture advanced biomedical devices and research platforms, such as organ-on-a-chip, artificial organs & cell therapy.


At Ourobionics, we play our part by providing advanced, faster, nanoscale, cell-protective bioelectric biofabrication technology. With the deep technology invented by our co-founders ( Suwan N. Jayasinghe Alireza Dolatshahi-Pirouz Alvaro Mata & Dr. Stephen G. Gray ) Ourobionics can produce high-throughput complex human tissues merged with bioelectronics and disease biosensors.

Hereby we would like to thank Janny van den Eijnden-van Raaij as one of the initiators of "biomedical devices domain" and understanding the importance of advancements in this field.


NXTGEN HIGHTECH initiative will accelerate our mission to speed up drug discovery, lower the costs of pharma R&D, and replace animal testing.



The official press release: https://lnkd.in/e5Xapw27 (click "Download English version")


About NXTGEN HIGHTECH


This project is made possible in part by a contribution from the National Growth Fund program NXTGEN HIGHTECH. This program will invest as much as € 1 billion until 2030 in more than 60 projects and in six essential domains. In doing so, NXTGEN HIGHTECH will make a significant contribution to the structural and sustainable economic growth in the Netherlands and offer solutions for the major societal challenges in the areas of energy transition, health, safety and food.

3 views0 comments

コメント


bottom of page